M H Bar

A randomized phase II trial of continuous infusion interleukin-2 or bolus injection interleukin-2 plus lymphokine-activated killer cells for advanced renal cell carcinoma.

Geoffrey R. Weiss, Kim Margolin, Frederick R. Aronson et al. · Journal of Clinical Oncology · 1992 · 159 citations

Medicine, Oncology, Pharmacology +17

A phase II study of high-dose continuous infusion interleukin-2 with lymphokine-activated killer cells in patients with metastatic melanoma.

Janice P. Dutcher, Ellen R. Gaynor, David H. Boldt et al. · Journal of Clinical Oncology · 1991 · 98 citations

Pharmacy, Immunology, Oncology +17

Therapy of renal cell carcinoma with interleukin-2 and lymphokine-activated killer cells: phase II experience with a hybrid bolus and continuous infusion interleukin-2 regimen.

David Parkinson, Richard I. Fisher, Anthony A. Rayner et al. · Journal of Clinical Oncology · 1990 · 87 citations

Medicine, Immunology, Oncology +16

Metastatic malignant melanoma treated with combined bolus and continuous infusion interleukin-2 and lymphokine-activated killer cells.

M H Bar, Mario Sznol, Michael B. Atkins et al. · Journal of Clinical Oncology · 1990 · 81 citations

Medicine, Immunology, Oncology +17

Pathogenesis of pulmonary edema during interleukin-2 therapy: correlation of chest radiographic and clinical findings in 54 patients.

Richard R. Saxon, J S Klein, M H Bar et al. · American Journal of Roentgenology · 1991 · 49 citations

Medicine, Immunology, Oncology +13